MicroRNA31-NDRG3 regulation axes are essential for hepatocellular carcinoma survival and drug resistance

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Cancer Biomarkers

• Publication date

  2017-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3233/CBM-170568PMID 28269758
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• New Approaches in Locoregional Therapies for Hepatocellular Carcinoma

  2016cited by this paper
• MiR-31 Functions as a Tumor Suppressor in Lung Adenocarcinoma Mainly by Targeting HuR.

  2016cited by this paper
• MicroRNA-31 functions as a tumor suppressor and increases sensitivity to mitomycin-C in urothelial bladder cancer by targeting integrin α5

  2016cited by this paper
• IER5 promotes irradiation- and cisplatin-induced apoptosis in human hepatocellular carcinoma cells.

  2016cited by this paper
• Upregulation of microRNA-31 targeting integrin α5 suppresses tumor cell invasion and metastasis by indirectly regulating PI3K/AKT pathway in human gastric cancer SGC7901 cells

  2016cited by this paper
• MicroRNA-155-3p promotes hepatocellular carcinoma formation by suppressing FBXW7 expression

  2016cited by this paper
• Hsa-mir-1269 genetic variant contributes to hepatocellular carcinoma susceptibility through affecting SOX6.

  2015cited by this paper
• MicroRNA-31 initiates lung tumorigenesis and promotes mutant KRAS-driven lung cancer.

  2015cited by this paper
• Tumor suppressor microRNA-31 inhibits gastric carcinogenesis by targeting Smad4 and SGPP2

  2015cited by this paper
• Growth-inhibitory and chemosensitizing effects of microRNA-31 in human glioblastoma multiforme cells.

  2015cited by this paper
• Loss of tumor suppressive microRNA-31 enhances TRADD/NF-κB signaling in glioblastoma

  2015cited by this paper
• Down-regulation of miR-503 expression predicate advanced mythological features and poor prognosis in patients with NSCLC.

  2015cited by this paper
• MicroRNAs in Hepatocellular Carcinoma: Carcinogenesis, Progression, and Therapeutic Target

  2014cited by this paper
• The diverse role of miR‐31 in regulating cancer associated phenotypes

  2013cited by this paper
• Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics

  2012cited by this paper
• MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest.

  2011cited by this paper
• MicroRNAs: Processing, Maturation, Target Recognition and Regulatory Functions.

  2011cited by this paper
• Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4–AKT–ATP‐binding cassette G2 pathway

  2010cited by this paper
• MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells.

  2010cited by this paper
• LAPTM4B: A novel cancer-associated gene motivates multidrug resistance through efflux and activating PI3K/AKT signaling

  2010cited by this paper
• Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance.

  2010cited by this paper
• Octamer 4 ( Oct 4 ) Mediates Chemotherapeutic Drug Resistance in Liver Cancer Cells Through a Potential Oct 4 – AKT – ATP-Binding Cassette G 2 Pathway

  2010cited by this paper
• Implication of microRNAs in drug resistance for designing novel cancer therapy.

  2010cited by this paper
• Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding

  2009cited by this paper
• Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib.

  2009cited by this paper
• Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies

  2009cited by this paper
• MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells.

  2009cited by this paper
• Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma.

  2007cited by this paper
• Phase III randomized controlled trial comparing the survival of patients with unresectable hepatocellular carcinoma treated with nolatrexed or doxorubicin.

  2007cited by this paper
• Riboregulator H19 induction of MDR1-associated drug resistance in human hepatocellular carcinoma cells

  2007cited by this paper
• Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines.

  2006cited by this paper
• A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma.

  2005cited by this paper
• Human hepatocellular carcinoma (HCC) cells require both alpha3beta1 integrin and matrix metalloproteinases activity for migration and invasion.

  2001cited by this paper
• Human Hepatocellular Carcinoma (HCC) Cells Require Both α3β1 Integrin and Matrix Metalloproteinases Activity for Migration and Invasion

  2001cited by this paper
• Estimating the world cancer burden: Globocan 2000

  2001cited by this paper
• Prognostic factors after hepatectomy for hepatocellular carcinomas. A univariate and multivariate analysis

  1990cited by this paper

• Elevated N-Myc downstream-regulated gene 3 expression indicates poor survival in epithelial ovarian cancer

  2025cites this paper
• Developing Potent Therapeutics for Liver Cancer Chemoresistance via an RNA Nanotech and Series-Circuit-Christmas-Bulb Mechanism Targeting ABC Transporters.

  2025cites this paper
• miR-184 in hepatocellular carcinoma: a promising therapeutic target

  2025cites this paper
• Dual role of microRNA-31 in human cancers; focusing on cancer pathogenesis and signaling pathways.

  2024cites this paper
• NDRG3 regulates imatinib resistance by promoting β‑catenin accumulation in the nucleus in chronic myelogenous leukemia

  2023cites this paper
• NIR Plasmonic Nanozymes: Synergistic Enhancement Mechanism and Multi‐Modal Anti‐Infection Applications of MXene/MOFs

  2023cites this paper
• Prognostic microRNA signature for estimating survival in patients with hepatocellular carcinoma.

  2023cites this paper
• CTRR-ncRNA: A Knowledgebase for Cancer Therapy Resistance and Recurrence Associated Non-coding RNAs

  2022cites this paper
• Relationship between serum NDRG3 and papillary thyroid carcinoma

  2022cites this paper
• miRNAs inspirations in hepatocellular carcinoma: Detrimental and favorable aspects of key performers.

  2022cites this paper
• Exome hits demystified: The next frontier.

  2021cites this paper
• Role of Micro-RNA in the Regulation of Cell Polarization in Hepatocellular Carcinoma

  2021cites this paper
• Proteome dynamics at broken replication forks reveal a distinct ATM-directed repair response suppressing DNA double-strand break ubiquitination

  2021cites this paper
• miR-31 Modulates Liver Cancer HepG2 Cell Apoptosis and Invasion via ROCK1/F-Actin Pathways

  2020cites this paper
• Unique microRNA alterations in hepatocellular carcinomas arising either spontaneously or due to chronic exposure to Ginkgo biloba extract (GBE) in B6C3F1/N mice

  2020cites this paper
• miR-9 and miR-263 Regulate the Key Genes of the ERK Pathway in the Ovary of Mud Crab Scylla paramamosain

  2020cites this paper
• miR-31 Modulates Liver Cancer HepG2 Cell Apoptosis and Invasion via ROCK1/F-Actin Pathways

  2020cites this paper
• The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma

  2019cites this paper
• miR-139 inhibits osteosarcoma cell proliferation and invasion by targeting ROCK1.

  2019cites this paper
• High NDRG3 expression facilitates HCC metastasis by promoting nuclear translocation of β-catenin

  2019cites this paper
• Association between the expression of carbonic anhydrase II and clinicopathological features of hepatocellular carcinoma.

  2019cites this paper
• Methylation-Mediated Silencing of MicroRNA-211 Decreases the Sensitivity of Melanoma Cells to Cisplatin

  2019cites this paper
• Improved Loading of Plasma-Derived Extracellular Vesicles to Encapsulate Antitumor miRNAs

  2019cites this paper
• Nervous NDRGs: the N-myc downstream–regulated gene family in the central and peripheral nervous system

  2019cites this paper
• MiR-129-5p inhibits liver cancer growth by targeting calcium calmodulin-dependent protein kinase IV (CAMK4)

  2019cites this paper
• MiR-223-3p Alleviates Vascular Endothelial Injury by Targeting IL6ST in Kawasaki Disease

  2019cites this paper
• SNHG20/miR-140-5p/NDRG3 axis contributes to 5-fluorouracil resistance in gastric cancer

  2019cites this paper
• Non-coding RNA in drug resistance of hepatocellular carcinoma

  2018cites this paper
• NDRG3 overexpression is associated with a poor prognosis in patients with hepatocellular carcinoma

  2018cites this paper
• Increased Expression of NDRG3 in Mouse Uterus During Embryo Implantation and in Mouse Endometrial Stromal Cells During In Vitro Decidualization

  2018cites this paper
• The Role of MicroRNAs in Hepatocellular Carcinoma

  2018cites this paper
• Role of microRNAs in the main molecular pathways of hepatocellular carcinoma

  2018cites this paper
• High expression of NDRG3 associates with unfavorable overall survival in non-small cell lung cancer

  2017cites this paper
• MiR-143 regulates the proliferation and migration of osteosarcoma cells through targeting MAPK7.

  2017cites this paper